- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about SAGE
Recent news which mentions SAGE
From Motley Fool
Why Shares of Sage Therapeutics Slumped This Week
August 11, 2023
From Motley Fool
Consolidated Water, Spectrum Brands, Arco Platform, Semler Scientific And Other Big Stocks Moving Higher On Friday
August 11, 2023
From Benzinga
2 Beaten-Down Stocks That Still Aren't Worth Buying
August 11, 2023
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
August 08, 2023
From Benzinga
Is Sage Therapeutics a Contrarian Buy?
August 08, 2023
From Motley Fool
From Benzinga
Dow Gains 1%; Tabula Rasa HealthCare Shares Spike Higher
August 07, 2023
From Benzinga
What More Can Support Biogen/Sage's Zuranolone Resubmission: Analysts See Uncertain Road Ahead
August 07, 2023
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 07, 2023
From Benzinga
Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 07, 2023
From Benzinga
FDA's Rejection of Sage/Biogen's Zuranolone Boosts Prospects for Axsome's Auvelity, Analyst Says
August 07, 2023
From Benzinga
Crude Oil Down Over 1%; Henry Schein Earnings Top Views
August 07, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 7, 2023
August 07, 2023
From Benzinga
Sage Therapeutics’ stock drops 49% after FDA approves zuranolone for postpartum depression but not for major depressive disorder
August 07, 2023
From MarketWatch
From Benzinga
From InvestorPlace
Dow Jumps 250 Points; Tyson Foods Posts Downbeat Results
August 07, 2023
From Benzinga
Why Is Sage Therapeutics (SAGE) Stock Down 48% Today?
August 07, 2023
From InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 07, 2023
From Benzinga
FDA Approves Sage Therapeutics/Biogen's Zuranolone For One Type Of Depression, Rejects For Another
August 07, 2023
From Benzinga
From Benzinga
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.